Companies Like Twist Bioscience Can Afford To Invest In Growth
TWST Stock | USD 47.33 2.02 4.46% |
Slightly above 69 percent of all Twist Bioscience's private investors are curious in acquiring. The analysis of the overall investor sentiment regarding Twist Bioscience Corp suggests that a large number of traders are confidant. Twist Bioscience's investing sentiment can be driven by a variety of factors including economic data, Twist Bioscience's earnings reports, geopolitical events, and overall market trends.
Twist |
Theres no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Read at finance.yahoo.com
Twist Bioscience Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Twist Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Twist Bioscience Maximum Pain Price Across January 17th 2025 Option Contracts
Twist Bioscience's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Twist Bioscience close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Twist Bioscience's options.
Twist Bioscience Fundamental Analysis
We analyze Twist Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Twist Bioscience is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Twist Bioscience Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Twist Bioscience stock to make a market-neutral strategy. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics with similar companies.
Peers
Twist Bioscience Related Equities
GH | Guardant Health | 10.51 | ||||
PSNL | Personalis | 7.02 | ||||
NTRA | Natera | 4.36 | ||||
ILMN | Illumina | 3.88 | ||||
CDNA | Caredx | 3.44 | ||||
DHR | Danaher | 2.30 | ||||
EXAS | EXACT Sciences | 2.17 | ||||
CSTL | Castle Biosciences | 2.03 | ||||
TMO | Thermo Fisher | 1.81 | ||||
A | Agilent Technologies | 1.69 | ||||
MTD | Mettler Toledo | 1.43 | ||||
IQV | IQVIA Holdings | 1.16 | ||||
WAT | Waters | 0.95 | ||||
ICLR | ICON PLC | 0.31 |
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.